Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
V. Herrera
Observed names:
Herrera, V.,
V Herrera
Institution:
Novartis (United States)
Observed institutions:
Novartis (United States),
Express Scripts Holding Company (United States)
OpenAlex ID:
A5113050299
Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes
2010
·
R. E. Aubert
, V. Herrera
, et al.
·
Diabetes Obesity and Metabolism
·
141
Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial
2013
·
S L Charland
, B C Agatep
, et al.
·
The Pharmacogenomics Journal
·
48
Assessment of treatment patterns associated with injectable disease-modifying therapy among relapsing–remitting multiple sclerosis patients
2017
·
J Nicholas
, JJ Ko
, et al.
·
Multiple Sclerosis Journal - Experimental Translational and Clinical
·
13
FRI0580 Comorbidity Burden and Medication Use between Psoriatic Arthritis Patients with Moderate-To-Severe Psoriasis vs. Those with Minimal Skin Psoriasis in The US
2016
·
J.F. Merola
, V. Herrera
, et al.
·
Annals of the Rheumatic Diseases
·
2
AB0808 Clinical Factors That Modify Treatment Effects of Biologics in Psoriatic Arthritis: A Systematic Review and Meta-Regression
2015
·
J.B. Palmer
, S. Kanter
, et al.
·
Annals of the Rheumatic Diseases
·
2
Real-World use of Secukinumab Among Patients with Psoriasis: Patient Characteristics and Dosing
2016
·
Y Zhao
, JJ Wu
, et al.
·
Value in Health
·
1
Mortality risk in Patients with Psoriasis
2015
·
S.R. Feldman
, N. Princic
, et al.
·
Value in Health
·
1
PRM26 The Use of Claims-Based CHA2DS2-VASc and ATRIA Scores to Predict Stroke/Systemic Embolism and Bleeding Rates Among Anticoagulated Patients With Atrial Fibrillation (AFIB) in a Pharmacy-Benefit Management (PBM) Environment
2012
·
D.C. Malone
, S.L. Charland
, et al.
·
Value in Health
·
1
Supplementary Material for: Exploration of the Product of the 5-Point Investigator’s Global Assessment and Body Surface Area (IGA × BSA) as a Practical Minimal Disease Activity Goal in Patients with Moderate-to-Severe Psoriasis
2019
·
Gottlieb, A.B.
, Germino, R.
, et al.
·
Figshare
SAT0411 Biologic Discontinuations among Patients with Psoriatic Arthritis: Results from Corrona Psoriatic Arthritis/spondyloarthritis Registry
2016
·
P.J. Mease
, C. Karki
, et al.
·
Annals of the Rheumatic Diseases
THU0377 Are Patients with Ankylosing Spondylitis Really Different from Non-Radiographic Axial SPA: Results from Corrona Psoriatic Arthritis/spondyloarthritis Registry
2016
·
P.J. Mease
, C. Karki
, et al.
·
Annals of the Rheumatic Diseases
Economic Impact of Above-label Dosing With Biologics in Patients With Moderate to Severe Psoriatic Arthritis
2016
·
S. Schwartzman
, M. Tran
, et al.
·
Value in Health
PDF
A Qualitative Assessment of Multiple Sclerosis Patients’ Experiences with Disease Modifying Therapies
2016
·
A Thach
, C Brown
, et al.
·
Value in Health
AB0810 Clinical Factors That Modify the Effects of Biologics on Quality of Life: A Case Study in Psoriatic Arthritis
2015
·
J.B. Palmer
, S. Kanter
, et al.
·
Annals of the Rheumatic Diseases
AB0809 Unmet Needs Still Remain in the Biologic Therapy Options for Psoriatic Arthritis
2015
·
S. Gabriel
, E. Sullivan
, et al.
·
Annals of the Rheumatic Diseases
Efficacy of Secukinumab in patients with Plaque Psoriasis: area under the curve of treatment response rates
2015
·
A.W. Armstrong
, S.R. Feldman
, et al.
·
Value in Health
Describing Treatment Patterns In Adolescents And Adults With Allergic Asthma
2015
·
S. Gabriel
, T. Karagiannis
, et al.
·
Value in Health
PDF
Treatment Modifications and Costs of Biologic Therapy In Patients With Ankylosing Spondylitis
2015
·
J.B. Palmer
, Y. Li
, et al.
·
Value in Health
Timing of First-Time use of Biologics and Healthcare Costs and Utilization in Psoriasis
2015
·
S.R. Feldman
, V. Herrera
, et al.
·
Value in Health
PRM31 Assessment of Adoption of United States Prescribing Guidelines for Dabigatran in a Real World Population
2012
·
B.J. Schrader
, S.L. Charland
, et al.
·
Value in Health
PDB105 Payor and Prescriber Feasibility Assessment of a Pharmacy Benefit Management (PBM) Diabetes Program Utilizing Pharmacist-Advised Self-Adjusted Basal Insulin
2012
·
G. Hamid
, B.J. Schrader
, et al.
·
Value in Health
PSY53 Changes in Concomitant therapy for Weight-related Illness Following Initiation of Weight Loss Pharmacotherapy
2011
·
B.C. Agatep
, S.L. Charland
, et al.
·
Value in Health
Show more works
View as search
Works count:
22
Citation count:
209
H-index:
3
I10-index:
3
Year
Topic
Type